Home
Healthcare
Medical Devices & Supplies
Isothermal Nucleic Acid Amplification Technology Market 2030

Isothermal Nucleic Acid Amplification Technology Market

Name: Growth Market Reports
Address: 500 East E Street, Ontario, 91764, USA
Telephone: +1 909 414 1393

Segments - by Products (Instrument and Reagent), Technology (NASBA, HAD, LAMP, SDA, SPIA, NEAR, TMA, RCA, RPA, SMAP2, and Others), Applications (Blood Screening, Infectious Disease Diagnostics, Cancer, and Others), End-users (Hospitals, Central & Reference Labs, and Others), and Regions (Asia Pacific, North America, Latin America, Europe, and Middle East & Africa) - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast 2021 – 2028

HC-1246
4.6 Rating
190 Pages

Upcoming
68 Reviews

Author :

Raksha Sharma

Fact-checked by :

Vineet Pandey

Editor :

Vishal Golekar

Report Description

The global isothermal nucleic acid amplification technology market size is projected to expand at a substantial CAGR during the forecast period, 2021–2028. The growth of the market is attributed to the rising prevalence of infectious diseases.

In the field of molecular biology and recombinant DNA technologies, the isothermal nucleic acid amplification technology (INAAT) is primarily used to identify and analyze nucleic acids. This technique is often used to diagnose infectious, genetic, and inherited disorders quickly, accurately, and precisely using DNA, RNA, cells, proteins, small molecules, and ions. The amplicons created by this technique are used to make a variety of nucleic acid nanomaterials that are employed in biomedicine, bioimaging, and biosensing. They are also used to test for HIV, Tuberculosis, influenza, hepatitis A and B, chlamydia, and gonorrhea (CT/NG), among other infectious disorders.

Wide the rising demand for advanced diagnostic technology, the development of recombinase polymerase amplification (RPA), single primer isothermal amplification (SPIA), and strand displacement amplification (SDA) are key aspects for the market expansion.

Market Trends, Drivers, Restraints, and Opportunities

Increasing number of cancer and other chronic conditions along with growing demand for effective diagnostic and treatment options are expected to drive the market growth during the forecast period.
Wide applications of loop-mediated isothermal amplification (LAMP) tests for DNA and RNA amplification as well as the detection of genetically modified organisms (GMOs) are expected to boost the market growth.
Rising number of aging population worldwide and the increase in the adoption of INAAT over other molecular diagnostic techniques are major factors driving the market growth during the forecast period.
Stringent rules imposed by organizations such as World Health Organization (WHO) as well as wide reluctance to replace conventional PCR solutions with newer ones among patients in low-income nations are projected to hamper the market growth.
Lack of awareness and relatively high cost of the advanced diagnostics present as key challenges that can restrict the market expansion during the forecast period.
Ongoing R&D in the field of microbiology and rapid technological advancements to develop high-ended diagnostic devices are projected to offer lucrative opportunities for the market players.

Scope of the Report

The report on the global isothermal nucleic acid amplification technology market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.

Attributes	Details
Report Title	Isothermal Nucleic Acid Amplification Technology Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast
Base Year	2020
Historic Data	2018–2019
Forecast Period	2021–2028
Segmentation	Products (Instrument and Reagent), Technology (NASBA, HAD, LAMP, SDA, SPIA, NEAR, TMA, RCA, RPA, SMAP2, and Others), Applications (Blood Screening, Infectious Disease Diagnostics, Cancer, and Others), and End-users (Hospitals, Central & Reference Labs, and Others)
Regional Scope	Asia Pacific, North America, Latin America, Europe, and Middle East & Africa
Report Coverage	Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast
Key Players Covered in the Report	Alere, Inc.; bioMerieux SA; Eiken Chemical Co. Ltd.; Hologic, Inc. (Gen-Probe); Lucigen; QIAGEN; Quidel Corporation; Thermo Fisher Scientific; and Becton, Dickinson & Company

Market Segment Insights

Reagent segment is expected to hold a key share of the market
Based on products, the isothermal nucleic acid amplification technology market is bifurcated into instrument and reagent. The reagent segment is expected to hold a key share of the market during the forecast period owing to considerable usage of the products in hospitals and primary healthcare settings. Consumables and reagents are widely utilized as compared to instruments, which is extensively propelled by growing R&D programs and activities from key players. However, the instruments segment is anticipated to expand at a rapid pace during the forecast period due to the introduction of devices that are improved in terms of precision, speed, and portability.

TMA segment to account for a key market share
On the basis of technology, the market is segmented into SDA, SPIA, NEAR, RCA, RPA, SMAP2, nucleic acid sequence-based amplification (NASBA), helicase-dependent amplification (HDA), loop-mediated isothermal amplification (LAMP), transcription-mediated amplification (TMA), and Others. The TMA segment is expected to account for a key share of the market during the forecast period as it is one of the most commercial successful technology widely employed by the players and was the first INAAT introduced in the market. On the other hand, the LAMP and HDA segment is anticipated to expand at a rapid pace during the forecast period.

Infectious disease diagnostics segment is expected to hold a major market share
In terms of applications, the isothermal nucleic acid amplification technology market is segmented into blood screening, infectious disease diagnostics, cancer, and others. The Infectious disease diagnostics segment is expected to hold a major share of the market during the forecast period owing to the introduction of more particular kits and the rising prevalence of disorders such as HIV, hepatitis A and B, and STDs such as chlamydia and gonorrhea. In addition, the growing demand for quick testing to diagnose infectious diseases and prevent the diseases spread particularly in low-income countries is likely to drive growth.

On the other hand, the blood screening segment is anticipated to expand at a rapid pace during the forecast period owing to increased number of blood transfusions across the world. INAAT is extensively used to screen transfused blood for infectious organisms in order to prevent epidemics and limit their spread.

Hospitals segment is expected to register a high CAGR
Based on end-users, the market is divided into hospitals, central & reference labs, and others. The hospitals segment is expected to register a high CAGR during the forecast period due to wide adoption of wireless communication and miniaturized point-of-care devices are being developed, offering single-level access to diagnostic results across the hospital. Automation of a large quantity of samples for infectious disease diagnosis and a requirement for accurate results offered by hospitals are all expected to boost the segment growth.

On the other hand, the central & reference labs segment is anticipated to expand at a rapid pace during the forecast period due to an increasing number of reference laboratories and high adoption of novel & accurate molecular diagnostic techniques.

North America segment is anticipated to dominate the market
On the basis of regions, the isothermal nucleic acid amplification technology market is classified as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. North America is anticipated to dominate the market with an impressive CAGR during the forecast period. The regional market growth can be attributed to established research infrastructure and rising research initiatives in economies such as the US and Canada. Moreover, increasing demand and investments from foreign players to develop advanced technology for diagnostics products by expanding the scope for the existing research activities in the region play key roles in the regional market expansion.

On the other hand, the market in Asia Pacific is expected to exhibit a rapid growth rate in the coming years owing to increase in disposable income, increased investments in healthcare facilities, and unfulfilled clinical demands.

Segments

Segments Covered in the Report
The global isothermal nucleic acid amplification technology market has been segmented on the basis of

Products

Instrument
Reagent

Technology

NASBA
HDA
LAMP
SDA
SPIA
NEAR
TMA
RCA
RPA
SMAP2
Others

Applications

Blood Screening
Infectious Disease Diagnostics
Cancer
Others

End-users

Hospitals
Central & Reference Labs
Others

Regions

Asia Pacific
North America
Latin America
Europe
Middle East & Africa

Key Players

Alere, Inc.
BioMerieux SA
Eiken Chemical Co. Ltd.
Hologic, Inc. (Gen-Probe)
Lucigen
QIAGEN
Quidel Corporation
Thermo Fisher Scientific
Becton, Dickinson & Company

Competitive Landscape

Key players competing in the isothermal nucleic acid amplification technology market are Alere, Inc.; bioMerieux SA; Eiken Chemical Co. Ltd.; Hologic, Inc. (Gen-Probe); Lucigen; QIAGEN; Quidel Corporation; Thermo Fisher Scientific; and Becton, Dickinson & Company.

Several of these key players are actively engaged in the adoption of various business strategies such as mergers, acquisitions, partnerships, collaborations, capacity expansion, and Customized products and applications, which are likely to enhance their market shares.

Isothermal Nucleic Acid Amplification Technology Market by Key Players

Table Of Content

1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Isothermal Nucleic Acid Amplification Technology Market Overview
  4.1. Introduction
     4.1.1. Market Taxonomy
     4.1.2. Market Definition
  4.2. Macro-Economic Factors
     4.2.1. Industry Outlook
  4.3. Isothermal Nucleic Acid Amplification Technology Market Dynamics
     4.3.1. Market Drivers
     4.3.2. Market Restraints
     4.3.3. Opportunity
     4.3.4. Market Trends
  4.4. Isothermal Nucleic Acid Amplification Technology Market - Supply Chain
  4.5. Global Isothermal Nucleic Acid Amplification Technology Market Forecast
     4.5.1. Isothermal Nucleic Acid Amplification Technology Market Size (US$ Mn) and Y-o-Y Growth
     4.5.2. Isothermal Nucleic Acid Amplification Technology Market Size (000â€™ Units) and Y-o-Y Growth
     4.5.3. Isothermal Nucleic Acid Amplification Technology Market Absolute $ Opportunity
5. Global Isothermal Nucleic Acid Amplification Technology Market Analysis and Forecast by Applications
  5.1. Market Trends
  5.2. Introduction
     5.2.1. Basis Point Share (BPS) Analysis by Applications
     5.2.2. Y-o-Y Growth Projections by Applications
  5.3. Isothermal Nucleic Acid Amplification Technology Market Size and Volume Forecast by Applications
     5.3.1. Blood Screening
     5.3.2. Infectious Disease Diagnostics
     5.3.3. Cancer
     5.3.4. Others
  5.4. Absolute $ Opportunity Assessment by Applications
  5.5. Market Attractiveness/Growth Potential Analysis by Applications
6. Global Isothermal Nucleic Acid Amplification Technology Market Analysis and Forecast by End Users
  6.1. Market Trends
  6.2. Introduction
     6.2.1. Basis Point Share (BPS) Analysis by End Users
     6.2.2. Y-o-Y Growth Projections by End Users
  6.3. Isothermal Nucleic Acid Amplification Technology Market Size and Volume Forecast by End Users
     6.3.1. Hospitals
     6.3.2. Central & Reference Labs
     6.3.3. Others
  6.4. Absolute $ Opportunity Assessment by End Users
  6.5. Market Attractiveness/Growth Potential Analysis by End Users
7. Global Isothermal Nucleic Acid Amplification Technology Market Analysis and Forecast by Region
  7.1. Market Trends
  7.2. Introduction
     7.2.1. Basis Point Share (BPS) Analysis by Region
     7.2.2. Y-o-Y Growth Projections by Region
  7.3. Isothermal Nucleic Acid Amplification Technology Market Size and Volume Forecast by Region
     7.3.1. North America
     7.3.2. Latin America
     7.3.3. Europe
     7.3.4. Asia Pacific
     7.3.5. Middle East and Africa (MEA)
  7.4. Absolute $ Opportunity Assessment by Region
  7.5. Market Attractiveness/Growth Potential Analysis by Region
  7.6. Global Isothermal Nucleic Acid Amplification Technology Demand Share Forecast, 2019-2026
8. North America Isothermal Nucleic Acid Amplification Technology Market Analysis and Forecast
  8.1. Introduction
     8.1.1. Basis Point Share (BPS) Analysis by Country
     8.1.2. Y-o-Y Growth Projections by Country
  8.2. North America Isothermal Nucleic Acid Amplification Technology Market Size and Volume Forecast by Country
     8.2.1. U.S.
     8.2.2. Canada
  8.3. Absolute $ Opportunity Assessment by Country
  8.4. North America Isothermal Nucleic Acid Amplification Technology Market Size and Volume Forecast by Applications
     8.4.1. Blood Screening
     8.4.2. Infectious Disease Diagnostics
     8.4.3. Cancer
     8.4.4. Others
  8.5. Basis Point Share (BPS) Analysis by Applications
  8.6. Y-o-Y Growth Projections by Applications
  8.7. North America Isothermal Nucleic Acid Amplification Technology Market Size and Volume Forecast by End Users
     8.7.1. Hospitals
     8.7.2. Central & Reference Labs
     8.7.3. Others
  8.8. Basis Point Share (BPS) Analysis by End Users
  8.9. Y-o-Y Growth Projections by End Users
  8.10. Market Attractiveness/Growth Potential Analysis
     8.10.1. By Country
     8.10.2. By Product Type
     8.10.3. By Application
  8.11. North America Isothermal Nucleic Acid Amplification Technology Demand Share Forecast, 2019-2026
9. Latin America Isothermal Nucleic Acid Amplification Technology Market Analysis and Forecast
  9.1. Introduction
     9.1.1. Basis Point Share (BPS) Analysis by Country
     9.1.2. Y-o-Y Growth Projections by Country
     9.1.3. Latin America Average Pricing Analysis
  9.2. Latin America Isothermal Nucleic Acid Amplification Technology Market Size and Volume Forecast by Country
      9.2.1. Brazil
      9.2.2. Mexico
      9.2.3. Rest of Latin America
   9.3. Absolute $ Opportunity Assessment by Country
  9.4. Latin America Isothermal Nucleic Acid Amplification Technology Market Size and Volume Forecast by Applications
     9.4.1. Blood Screening
     9.4.2. Infectious Disease Diagnostics
     9.4.3. Cancer
     9.4.4. Others
  9.5. Basis Point Share (BPS) Analysis by Applications
  9.6. Y-o-Y Growth Projections by Applications
  9.7. Latin America Isothermal Nucleic Acid Amplification Technology Market Size and Volume Forecast by End Users
     9.7.1. Hospitals
     9.7.2. Central & Reference Labs
     9.7.3. Others
  9.8. Basis Point Share (BPS) Analysis by End Users
  9.9. Y-o-Y Growth Projections by End Users
  9.10. Market Attractiveness/Growth Potential Analysis
     9.10.1. By Country
     9.10.2. By Product Type
     9.10.3. By Application
  9.11. Latin America Isothermal Nucleic Acid Amplification Technology Demand Share Forecast, 2019-2026
10. Europe Isothermal Nucleic Acid Amplification Technology Market Analysis and Forecast
  10.1. Introduction
     10.1.1. Basis Point Share (BPS) Analysis by Country
     10.1.2. Y-o-Y Growth Projections by Country
     10.1.3. Europe Average Pricing Analysis
  10.2. Europe Isothermal Nucleic Acid Amplification Technology Market Size and Volume Forecast by Country
     10.2.1. Germany
     10.2.2. France
     10.2.3. Italy
     10.2.4. U.K.
     10.2.5. Spain
     10.2.6. Russia
     10.2.7. Rest of Europe
  10.3. Absolute $ Opportunity Assessment by Country
  10.4. Europe Isothermal Nucleic Acid Amplification Technology Market Size and Volume Forecast by Applications
     10.4.1. Blood Screening
     10.4.2. Infectious Disease Diagnostics
     10.4.3. Cancer
     10.4.4. Others
  10.5. Basis Point Share (BPS) Analysis by Applications
  10.6. Y-o-Y Growth Projections by Applications
  10.7. Europe Isothermal Nucleic Acid Amplification Technology Market Size and Volume Forecast by End Users
     10.7.1. Hospitals
     10.7.2. Central & Reference Labs
     10.7.3. Others
  10.8. Basis Point Share (BPS) Analysis by End Users
  10.9. Y-o-Y Growth Projections by End Users
  10.10. Market Attractiveness/Growth Potential Analysis
     10.10.1. By Country
     10.10.2. By Product Type
     10.10.3. By Application
  10.11. Europe Isothermal Nucleic Acid Amplification Technology Demand Share Forecast, 2019-2026
11. Asia Pacific Isothermal Nucleic Acid Amplification Technology Market Analysis and Forecast
  11.1. Introduction
     11.1.1. Basis Point Share (BPS) Analysis by Country
     11.1.2. Y-o-Y Growth Projections by Country
     11.1.3. Asia Pacific Average Pricing Analysis
  11.2. Asia Pacific Isothermal Nucleic Acid Amplification Technology Market Size and Volume Forecast by Country
     11.2.1. China
     11.2.2. Japan
     11.2.3. South Korea
     11.2.4. India
     11.2.5. Australia
     11.2.6. Rest of Asia Pacific (APAC)
  11.3. Absolute $ Opportunity Assessment by Country
  11.4. Asia Pacific Isothermal Nucleic Acid Amplification Technology Market Size and Volume Forecast by Applications
     11.4.1. Blood Screening
     11.4.2. Infectious Disease Diagnostics
     11.4.3. Cancer
     11.4.4. Others
  11.5. Basis Point Share (BPS) Analysis by Applications
  11.6. Y-o-Y Growth Projections by Applications
  11.7. Asia Pacific Isothermal Nucleic Acid Amplification Technology Market Size and Volume Forecast by End Users
     11.7.1. Hospitals
     11.7.2. Central & Reference Labs
     11.7.3. Others
  11.8. Basis Point Share (BPS) Analysis by End Users
  11.9. Y-o-Y Growth Projections by End Users
  11.10. Market Attractiveness/Growth Potential Analysis
     11.10.1. By Country
     11.10.2. By Product Type
     11.10.3. By Application
  11.11. Asia Pacific Isothermal Nucleic Acid Amplification Technology Demand Share Forecast, 2019-2026
12. Middle East & Africa Isothermal Nucleic Acid Amplification Technology Market Analysis and Forecast
  12.1. Introduction
     12.1.1. Basis Point Share (BPS) Analysis by Country
     12.1.2. Y-o-Y Growth Projections by Country
     12.1.3. Middle East & Africa Average Pricing Analysis
  12.2. Middle East & Africa Isothermal Nucleic Acid Amplification Technology Market Size and Volume Forecast by Country
     12.2.1. Saudi Arabia
     12.2.2. South Africa
     12.2.3. UAE
     12.2.4. Rest of Middle East & Africa (MEA)
  12.3. Absolute $ Opportunity Assessment by Country
  12.4. Middle East & Africa Isothermal Nucleic Acid Amplification Technology Market Size and Volume Forecast by Applications
     12.4.1. Blood Screening
     12.4.2. Infectious Disease Diagnostics
     12.4.3. Cancer
     12.4.4. Others
  12.5. Basis Point Share (BPS) Analysis by Applications
  12.6. Y-o-Y Growth Projections by Applications
  12.7. Middle East & Africa Isothermal Nucleic Acid Amplification Technology Market Size and Volume Forecast by End Users
     12.7.1. Hospitals
     12.7.2. Central & Reference Labs
     12.7.3. Others
  12.8. Basis Point Share (BPS) Analysis by End Users
  12.9. Y-o-Y Growth Projections by End Users
  12.10. Market Attractiveness/Growth Potential Analysis
     12.10.1. By Country
     12.10.2. By Product Type
     12.10.3. By Application
  12.11. Middle East & Africa Isothermal Nucleic Acid Amplification Technology Demand Share Forecast, 2019-2026
13. Competition Landscape
  13.1. Global Isothermal Nucleic Acid Amplification Technology Market: Market Share Analysis
  13.2. Isothermal Nucleic Acid Amplification Technology Distributors and Customers
  13.3. Isothermal Nucleic Acid Amplification Technology Market: Competitive Dashboard
  13.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
     13.4.1. Alere, Inc.
     13.4.2. BioMerieux SA
     13.4.3. Eiken Chemical Co. Ltd.
     13.4.4. Hologic, Inc. (Gen-Probe)
     13.4.5. Lucigen
     13.4.6. QIAGEN
     13.4.7. Quidel Corporation
     13.4.8. Thermo Fisher Scientific
     13.4.9. Becton, Dickinson & Company

Methodology

Purchase Premium Report

Buy Now

Request For Sample

Request For Customization

Enquiry Before Buying

Speak With Analyst

Customize This Report

Ask for Research To Be Focused On Specific Regions or Segments
Receive Data As Per Your Format and Definition
Companies Profiled based on Your Requirements
Breaking Down Competitive Landscape as per Your Requirements
Any Level of Customization

Our Clients

Client Testinomials

We needed a highly accurate and precise report, which Growth Market Reports delivered promptly. The company compiled information from a wide array of reliable agencies and sourcess.It is extremely satisfactory to be working with you.
Strategy Head of Major Tech Company

We were very pleased to contact Growth Market Reports as they tailored reports precisely as per our requirements. As we are dealing with the aerospace and defense industry, we need reports of high accuracy and substantial quality.
Major Player in Defense Industry

Extremely delighted to have a well-crafted report on “Global Packaging Solutions Market Research Report” from your team. Thank you for providing me with all our requirements and for incorporating our suggestions.
CMO of Leading Packaging Company from USA

I had a good experience working with Growth Market Reports as they were very open to all constructive changes in the report. I found that the report had its charm embedded with ample of data.
Founder and Managing Partner of Major Korean Company

Our company has been working with Growth Market Reports for some years now and we are very happy with the quality of the reports provided by the company.I, on behalf of my organization, would like to thank you for offering professional reports.
Global Consulting Firm

Quick Contact

+1 909 414 1393

sales@growthmarketreports.com

Growth Market Report

Certified By